Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573527
Effectiveness of Tele-Rehabilitation in Managing Rhomboid Trigger Points in Patients With Myofascial Pain SyndromeRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07573527Not Yet Recruiting
Not Applicable
Effectiveness of Tele-Rehabilitation in Managing Rhomboid Trigger Points in Pati...Riphah International Univ...
NCT07574294
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca TrevigianaCompleted
NCT07574294Completed
—
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca Trev...
NCT07574125
Article Title Impact of Targeted Nutrition Education on Dietary Knowledge, Attitudes, and PracticesUnited Arab Emirates UniversityCompletedNot Applicable
NCT07574125Completed
Not Applicable
Article Title Impact of Targeted Nutrition Education on Dietary Knowledge, Attit...United Arab Emirates Univ...
NCT07573007
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and ComplicationsMarmara University Pendik Training and Research HospitalNot Yet Recruiting
NCT07573007Not Yet Recruiting
—
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Comp...Marmara University Pendik...
NCT07573488
Sleep, Stress and Migraine - an Observational and Training StudySusanne WegenerRecruitingNot Applicable
NCT07573488Recruiting
Not Applicable
Sleep, Stress and Migraine - an Observational and Training StudySusanne Wegener
NCT07572019
Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical ThoracoscopyKafrelsheikh UniversityNot Yet RecruitingPhase 2
NCT07572019Not Yet Recruiting
Phase 2
Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical Thor...Kafrelsheikh University
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573761
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone FormationIstanbul Saglik Bilimleri UniversityEnrolling By Invitation
NCT07573761Enrolling By Invitation
—
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth...Istanbul Saglik Bilimleri...
NCT07573267
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karate AthletesIstinye UniversityCompletedNot Applicable
NCT07573267Completed
Not Applicable
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karat...Istinye University
NCT07573228
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesUniversity of VirginiaRecruitingNot Applicable
NCT07573228Recruiting
Not Applicable
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness...University of Virginia
NCT07572929
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic TransplantMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07572929Not Yet Recruiting
Phase 2
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Meas...Medical College of Wiscon...
NCT07574177
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular HealthUniversity of South AlabamaNot Yet RecruitingNot Applicable
NCT07574177Not Yet Recruiting
Not Applicable
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiova...University of South Alaba...
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07572669
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRecruitingPhase 2
NCT07572669Recruiting
Phase 2
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogen...Union Hospital, Tongji Me...
NCT07574424
Normative Values For Physical FitnessRiphah International UniversityEnrolling By Invitation
NCT07574424Enrolling By Invitation
—
Normative Values For Physical FitnessRiphah International Univ...
NCT07572175
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart AssociationNot Yet RecruitingPhase 2
NCT07572175Not Yet Recruiting
Phase 2
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart Associatio...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed3 (15%)
Enrolling by invitation2 (10%)
not_applicable9 (45%)
Phase 25 (25%)
Not Specified4 (20%)
Phase 12 (10%)